Css LLC Kala Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

  • $902 Million
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021
SELL
$6.24 - $9.58 $94,224 - $144,658
-15,100 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$7.5 - $11.11 $90,750 - $134,431
-12,100 Reduced 44.49%
15,100 $113,000
Q2 2020

Aug 14, 2020
SELL
$8.33 - $13.79 $64,974 - $107,562
-7,800 Reduced 22.29%
27,200 $286,000
Q1 2020

May 15, 2020
BUY
$3.83 - $8.79 $134,050 - $307,649
35,000 New
35,000 $308,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.82M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email